Arjo AB (publ) ARJO-B.ST STO · Healthcare · Sweden
36.38 kr -0.05% -0.02 kr
Summary
56 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- It has been profitable 6 years in a row.
What to watch
- Earnings per share fell by 9.3% a year over the last 3 years.
- Out of every 100 SEK of revenue, only 3.2 SEK is left as net profit.
- It missed profit estimates 4 times in the last 8 quarters.
- It earns only 4.5 SEK a year on every 100 SEK of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 25.6 SEK for 1 SEK of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (SEK)
Diluted EPS (SEK)
- Analyst estimate
Revenue grew by 3.9% a year over 5 years. Over the last 3 years it grew by 3.3% a year. Earnings per share fell by 9.3% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 SEK of revenue goes
- Cost of sales 61 SEK
- Research and development 1.2 SEK
- Sales and administration 30 SEK
- Taxes and other 4.8 SEK
- Net profit 3.2 SEK
Net profit, industry median (Medical - Distribution) 1.4 SEK
Out of every 100 SEK of revenue, 3.2 SEK is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 5.5 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail